Xenon Pharmaceuticals Inc. XENE
40.45 USD +1.28 (+3.27%)
At closeNov 10, 2026, 4:01 AM EST
41.46 +1.01 +2.50%
Pre-market · Nov 10, 4:01 AM ET
38.59 Day range 40.52
33.38 52-week range 72.66
- YTD
- -9.75%
- 1 year
- +5.75%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.50M | 0 | 0 | 9.43M | 18.44M | |
| 7.50M | 0 | 0 | 9.43M | 18.44M | |
| -373.07M | -279.30M | -214.05M | -129.14M | -78.99M | |
| -345.91M | -234.33M | -182.39M | -125.37M | -78.88M | |
| -4.36 | -3.01 | -2.73 | -2.06 | -1.77 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 199.16M | 142.71M | 148.64M | 57.24M | 175.69M | |
| 633.16M | 798.14M | 964.80M | 754.15M | 572.01M | |
| 51.40M | 43.24M | 36.88M | 32.65M | 21.97M | |
| 7.94M | 9.02M | 10.90M | 10.44M | 8.26M | |
| 581.76M | 754.90M | 927.92M | 721.50M | 550.03M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -279.12M | -181.39M | -151.11M | -101.03M | -69.50M | |
| 218.00M | 165.00M | -111.39M | -293.40M | -246.77M | |
| 117.11M | 12.13M | 353.52M | 278.47M | 447.54M | |
| -799.00K | -3.08M | -5.62M | -2.89M | -2.05M | |
| 56.45M | -5.93M | 91.40M | -118.45M | 130.68M |